Acute Myeloid Leukemia With Adverse Cytogenetic Risk

被引：0
作者：
Mrozek, Krzysztof [1 ]
Bloomfield, Clara D. [1 ]
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
来源：
ONCOLOGY-NEW YORK | 2012年 / 26卷 / 08期
关键词：
MONOSOMAL KARYOTYPE; EUROPEAN LEUKEMIANET; COMPLEX KARYOTYPE; CELL TRANSPLANTATION; PROGNOSTIC VALUE; CLASSIFICATION; ADULTS; RECOMMENDATIONS; ABERRATIONS; SYSTEM;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：714 / +
页数：2
相关论文
共 50 条
  • [31] Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
    Herold, Tobias
    Rothenberg-Thurley, Maja
    Grunwald, Victoria V.
    Janke, Hanna
    Goerlich, Dennis
    Sauerland, Maria C.
    Konstandin, Nikola P.
    Dufour, Annika
    Schneider, Stephanie
    Neusser, Michaela
    Ksienzyk, Bianka
    Greif, Philipp A.
    Subklewe, Marion
    Faldum, Andreas
    Bohlander, Stefan K.
    Braess, Jan
    Wormann, Bernhard
    Krug, Utz
    Berdel, Wolfgang E.
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    Metzeler, Klaus H.
    [J]. LEUKEMIA, 2020, 34 (12) : 3161 - 3172
  • [32] Prognostic role of ACTL10 in Cytogenetic Normal Acute Myeloid Leukemia
    Lai, Rui
    Zhang, Weilong
    He, Xue
    Liao, Xinhui
    Liu, Xiaoni
    Fu, Wei
    Yang, Ping
    Wang, Jing
    Hu, Kai
    Yuan, Xiaoliang
    Zhang, Xiuru
    Jing, Hongmei
    Liu, Weiyou
    [J]. JOURNAL OF CANCER, 2020, 11 (17): : 5150 - 5161
  • [33] Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease
    Shihadeh, Ferial
    Reed, Valerie
    Faderl, Stefan
    Medeiros, L. Jeffrey
    Mazloom, Ali
    Hadziahmetovic, Mersiha
    Kantarjian, Hagop
    Allen, Pamela
    Ballas, Leslie
    Pierce, Sherry
    Dabaja, Bouthaina
    [J]. CANCER, 2012, 118 (01) : 112 - 117
  • [34] Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia
    Gmidene, Abir
    Sennana, Hlima
    Wahchi, Ines
    Ben Youssef, Yosra
    Jeddi, Ramzi
    Elloumi, Moez
    Saad, Ali
    [J]. HEMATOLOGY, 2012, 17 (01) : 9 - 14
  • [35] Persistent cytogenetic abnormalities in patients undergoing intensive chemotherapy for acute myeloid leukemia
    Saini, Lalit
    Brandwein, Joseph
    Szkotak, Artur
    Ghosh, Sunita
    Sandhu, Irwindeep
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (01) : 121 - 128
  • [36] Acute myeloid leukemia: 2013 update on risk-stratification and management
    Estey, Elihu H.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (04) : 317 - 327
  • [37] Are the Conventional Risk Factors Still Valid for Acute Myeloid Leukemia Patients?
    Yildiz, Abdulkerim
    Maral, Senem
    Albayrak, Murat
    Pala, Cigdem
    Comert, Pinar
    Ozturk, Hacer Berna Afacan
    Sahin, Osman
    [J]. KONURALP TIP DERGISI, 2020, 12 (01): : 5 - 11
  • [38] Risk-adapted therapy in acute myeloid leukemia
    Fiegl, M.
    Hiddemann, W.
    [J]. INTERNIST, 2012, 53 (04): : 392 - +
  • [39] Unfavorable-risk cytogenetics in acute myeloid leukemia
    Hong, Wan-Jen
    Medeiros, Bruno C.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (02) : 173 - 184
  • [40] BCR-ABL+ acute myeloid leukemia: are we always dealing with a high-risk disease?
    Neuendorff, Nina Rosa
    Hemmati, Philipp
    Arnold, Renate
    Ihlow, Jana
    Doerken, Bernd
    Mueller-Tidow, Carsten
    Westermann, Joerg
    [J]. BLOOD ADVANCES, 2018, 2 (12) : 1409 - 1411
12345